4.8 Article

SynergyFinder 2.0: visual analytics of multi-drug combination synergies

Journal

NUCLEIC ACIDS RESEARCH
Volume 48, Issue W1, Pages W488-W493

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkaa216

Keywords

-

Funding

  1. Academy of Finland [292611, 310507, 313267, 326238]
  2. Cancer Society of Finland
  3. Sigrid Juselius Foundation
  4. European Union
  5. Academy of Finland (AKA) [326238, 326238, 313267, 310507, 310507, 292611, 313267, 292611] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

SynergyFinder (https://synergyfinder.fimm.fi) is a stand-alone web-application for interactive analysis and visualization of drug combination screening data. Since its first release in 2017, SynergyFinder has become a widely used web-tool both for the discovery of novel synergistic drug combinations in pre-clinical model systems (e.g. cell lines or primary patient-derived cells), and for better understanding of mechanisms of combination treatment efficacy or resistance. Here, we describe the latest version of SynergyFinder (release 2.0), which has extensively been upgraded through the addition of novel features supporting especially higher-order combination data analytics and exploratory visualization of multi-drug synergy patterns, along with automated outlier detection procedure, extended curve-fitting functionality and statistical analysis of replicate measurements. A number of additional improvements were also implemented based on the user requests, including new visualization and export options, updated user interface, as well as enhanced stability and performance of the web-tool. With these improvements, SynergyFinder 2.0 is expected to greatly extend its potential applications in various areas of multi-drug combinatorial screening and precision medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available